Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug access. Unclogging the pipeline.

S Jenks

    Medical World News
    |September 28, 1989
    PubMed
    Summary
    This summary is machine-generated.

    The Food and Drug Administration (FDA) drug approval process is improving, responding to patient needs. This change, spurred by AIDS, is expected to benefit patients with various serious diseases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey.

    Public health·2021
    Same author

    Oncologic emergencies in the emergency medicine residency curriculum: A national survey.

    The American journal of emergency medicine·2020
    Same author

    Gene therapy death--"everyone has to share in the guilt".

    Journal of the National Cancer Institute·2000
    Same author

    A gene therapy stamp? Not in this Century.

    Journal of the National Cancer Institute·1999
    Same author

    Cancer research funding now has many financial players.

    Journal of the National Cancer Institute·1999
    Same author

    In utero gene therapy is still a distant promise.

    Journal of the National Cancer Institute·1999
    Same journal

    Hospital ethics committees.

    Medical world news·1994
    Same journal

    Doctor to doctor:

    Medical world news·1993
    Same journal

    AMA endorsed involuntary HIV testing -- or did it?

    Medical world news·1991
    Same journal

    Genetic tests: can we afford the answers?

    Medical world news·1991
    Same journal

    Public Health: years of leadership and vision.

    Medical world news·1989
    Same journal

    Catastrophic care fallout gauged.

    Medical world news·1989
    See all related articles

    Area of Science:

    • Regulatory Science
    • Public Health Policy
    • Pharmaceuticals

    Background:

    • The Food and Drug Administration (FDA) drug approval process has historically faced criticism for being slow and cumbersome.
    • Patient advocacy groups and individuals have long protested the lengthy timelines, highlighting unmet medical needs.

    Purpose of the Study:

    • To examine the evolving landscape of the FDA's drug approval process.
    • To assess the impact of patient-driven advocacy on regulatory reform.
    • To understand the potential benefits for patients with serious diseases beyond Acquired Immunodeficiency Syndrome (AIDS).

    Main Methods:

    • Analysis of FDA approval timelines and policy changes.
    • Review of patient advocacy group activities and their influence.

    Related Experiment Videos

  • Qualitative assessment of regulatory system responsiveness.

    • Main Results:

    • The FDA's drug approval process is showing signs of acceleration, moving away from previous bottlenecks.
    • Regulatory reforms are increasingly aligning with patient needs and desires.
    • The Acquired Immunodeficiency Syndrome (AIDS) epidemic has been a significant catalyst for these changes.

    Conclusions:

    • The FDA is adapting its drug approval pathways to be more responsive to patient demands.
    • While AIDS drove initial reforms, broader patient populations with serious illnesses are anticipated to gain from these improvements.
    • The shift signifies a positive trend towards patient-centric drug regulation.